CC

Casdin Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 36.59%
This Quarter Est. Return
1 Year Est. Return
+36.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.28B
AUM Growth
-$235M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$18.9M
2
+$17.9M
3
+$16.5M
4
NVTA
Invitae Corporation
NVTA
+$14.7M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$14M

Top Sells

1
+$67.3M
2
+$24.7M
3
+$19.9M
4
VERV
Verve Therapeutics
VERV
+$17.2M
5
BPMC
Blueprint Medicines
BPMC
+$9.73M

Sector Composition

1 Healthcare 98.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$170M 13.2%
1,315,000
+90,000
2
$138M 10.67%
7,566,292
3
$97.2M 7.53%
39,527,669
4
$86.7M 6.72%
365,000
-283,000
5
$77.8M 6.03%
395,780
6
$64.7M 5.02%
1,477,800
-222,200
7
$60.1M 4.66%
2,525,000
+2,700
8
$51.9M 4.02%
9,505,000
-1,230,786
9
$45.3M 3.51%
3,030,648
-1,652,784
10
$44.3M 3.43%
2,290,571
-887,596
11
$36.2M 2.8%
1,300,000
+305,000
12
$32.4M 2.51%
1,675,000
+925,000
13
$31.6M 2.45%
12,604,275
14
$28M 2.17%
565,000
-402,000
15
$23M 1.78%
2,270,000
+620,000
16
$22.5M 1.74%
945,000
+580,000
17
$21.5M 1.67%
475,000
+225,000
18
$20.7M 1.6%
2,050,000
19
$18.9M 1.46%
+850,000
20
$17.3M 1.34%
1,850,000
+1,235,246
21
$16.8M 1.3%
9,038,388
+7,912,500
22
$16.5M 1.28%
+150,000
23
$16.4M 1.27%
3,206,380
24
$15.5M 1.2%
7,363,260
-355,333
25
$14.5M 1.12%
370,000
1
2